MUSCAT: Oman’s Royal Hospital issued a clarification about the shortages of some medicines due to coronavirus (Covid-19) pandemic.
In a statement issued online, Royal Hospital on Tuesday said it purchases more than 1,600 medicines from various countries but due to the pandemic crisis, there is a shortage of 16 medicines that are imported from outside. “We have taken a number of steps to obtain these 16 medicines,” the statement said.
Royal Hospital also clarified about the shortage of mitotane drug that is used for the treatment of adrenal cancer. “Mitotane is imported from UK in specific quantities because the number of patients are very limited for this case and we purchase it based on the requirements. However, this medicine will arrive soon,” the hospital added.
Read More
- Muscat Municipality trains SQU students in meat safety and veterinary inspection
- Dedicated ambulance service launched for bedridden patients in Muscat
- Struggling to pay electricity bills? Nama Supply offers flexible payment plans
- Muscat Governorate completes 95 km of internal roads across wilayats in 2026
- His Majesty Sultan Haitham confers Royal Orders on senior officials and leading figures
“We are dealing with relevant authorities to ensure that all our medicines are in stock but because of the pandemic, we may face some difficulties and that is everywhere” the statement added.
The hospital said in a statement: “According to what is being circulated about the availability of some medicines, we would like to clarify that the Royal Hospital purchases more than 1,600 medicines from various countries of the world to provide them to all patients.”
